hh.sePublications
Change search
Link to record
Permanent link

Direct link
BETA
Laurell, Hélène
Alternative names
Publications (10 of 25) Show all publications
Norell Pejner, M., Ourique de Morais, W., Lundström, J., Laurell, H. & Skärsäter, I. (2019). A Smart Home System for Information Sharing, Health Assessments, and Medication Self-Management for Older People: Protocol for a Mixed-Methods Study. JMIR Research Protocols, 8(4), Article ID e12447.
Open this publication in new window or tab >>A Smart Home System for Information Sharing, Health Assessments, and Medication Self-Management for Older People: Protocol for a Mixed-Methods Study
Show others...
2019 (English)In: JMIR Research Protocols, ISSN 1929-0748, E-ISSN 1929-0748, Vol. 8, no 4, article id e12447Article in journal (Refereed) Published
Abstract [en]

Background:

Older adults often want to stay in a familiar place, such as their home, as they get older. This so-called aging in place, which may involve support from relatives or care professionals, can promote older people’s independence and well-being. The combination of aging and disease, however, can lead to complex medication regimes, and difficulties for care providers in correctly assessing the older person's health. In addition, the organization of the health care is fragmented, which makes it difficult for health professionals to encourage older people to participate in their care. It is also a challenge to perform adequate health assessment and appropriate communication between health care professionals.

Objective:

The purpose of this paper is to describe the design for an integrated home-based system that can acquire and compile health-related evidence for guidance and information sharing among care providers and care receivers in order to support and promote medication self-management among older people.

Methods:

The authors used a participatory design (PD) approach for this mixed-method project, which was divided into four phases: Phase I, Conceptualization, consisted of the conceptualization of a system to support medication self- management, objective health assessments, and communication between health care professionals. Phase II, Development of a System, consisted of building and bringing together the conceptualized systems from phase I. Phases III (pilot study) and IV (a full-scale study) are described briefly.

Results:

Our participants in phase I were people who were involved in some way in the care of older adults, and included older adults themselves, relatives of older adults, care professionals, and industrial partners. With input from phase I participants, we identified two relevant concepts for promoting medication self-management, both of which related to systems that participants believed could provide guidance for the older adults themselves, relatives of older adults, and care professionals. The system will also encourage information sharing between care providers and care receivers. The first is the concept of the Intelligent Friendly Home (IAFH), defined as an integrated residential system that evolves to sense, reason and act in response to individual needs, preferences and behaviors as these change over time. The second concept is the MedOP system, a system that would be supported by the IAFH, and which consists of three related components: one that assess health behaviors, another that communicates health data, and a third that promotes medication self-management.

Conclusions:

The participants in this project were older adults, relatives of older adults, care professionals, and our industrial partners. With input from the participants, we identified two main concepts that could comprise a system for health assessment, communication and medication self- management: the Intelligent Friendly Home (IAFH), and the MedOP system. These concepts will be tested in this study to determine whether they can facilitate and promote medication self-management in older people. © The authors. All rights reserved. 

Place, publisher, year, edition, pages
Toronto: J M I R Publications, Inc., 2019
Keywords
assessments, medication, mixed methods, older people, self-management, smart homes
National Category
Nursing
Identifiers
urn:nbn:se:hh:diva-39753 (URN)10.2196/12447 (DOI)000466496800024 ()31038459 (PubMedID)
Available from: 2019-06-13 Created: 2019-06-13 Last updated: 2019-06-19
Laurell, H., Karlsson, N., Lindgren, J., Andersson, S. & Svensson, G. (2019). Re-testing and validating a triple bottom line dominant logic for business sustainability. Management of environmental quality, 30(3), 518-537
Open this publication in new window or tab >>Re-testing and validating a triple bottom line dominant logic for business sustainability
Show others...
2019 (English)In: Management of environmental quality, ISSN 1477-7835, E-ISSN 1758-6119, Vol. 30, no 3, p. 518-537Article in journal (Refereed) Published
Abstract [en]

The triple bottom line (TBL) is still commonly explored in research without joint consideration of economic, social and environmental elements of business sustainability (BS). The purpose of this paper is to re-test and validate a BS framework based on the TBL approach.This study is based on a questionnaire survey consisting of the largestfirms in corporate Sweden. A total of 107 usable questionnaires were ultimately received, for a response rate of 36.5 percent. The findings validate and extend a framework of a TBL-dominant logic for BS. A total of 19 dimensions indicating satisfactory validity and reliability of the BS framework were identified. The BS framework offers relevant insights to monitor and assess a TBL-dominant logic for BS. It also provides opportunities for further research. Managers can use the BS framework as a tool to map firm priorities in connection with BS. Each dimension of the BS framework offers insights into how to monitor and assess firms’ efforts in the TBL.This study contributes to validate and extend the TBL-dominant logic for BS. The BS framework also offers a timely and relevant contribution to both scholars and practitioners engaging in business sustainability. © 2018, Emerald Publishing Limited.

Place, publisher, year, edition, pages
Bingley: Emerald Group Publishing Limited, 2019
Keywords
Sweden, Validation, Business sustainability, Triple bottom line
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-38171 (URN)10.1108/MEQ-02-2018-0024 (DOI)000461046500002 ()2-s2.0-85053262807 (Scopus ID)
Available from: 2018-10-17 Created: 2018-10-17 Last updated: 2019-05-24Bibliographically approved
Karlsson, N. P. .., Laurell, H., Lindgren, J., Pehrsson, T., Andersson, S. & Svensson, G. (2018). A cross-country comparison and validation of firms’ stakeholder considerations in sustainable business practices. Corporate Governance : The International Journal of Effective Board Performance, 18(3), 408-424
Open this publication in new window or tab >>A cross-country comparison and validation of firms’ stakeholder considerations in sustainable business practices
Show others...
2018 (English)In: Corporate Governance : The International Journal of Effective Board Performance, ISSN 1472-0701, E-ISSN 1758-6054, Vol. 18, no 3, p. 408-424Article in journal (Refereed) Published
Abstract [en]

Purpose: The purpose of this study is to compare and validate firms’ internal and external stakeholder considerations in sustainable business practices across business settings. It aims to assess the validity and reliability of a stakeholder framework appearing in previous studies.

Design/methodology/approach: The study uses a questionnaire survey and a cross-industry sample consisting of the largest firms in corporate Sweden. Multivariate analysis tests the stakeholder framework. Each of the 294 key informants was initially identified and contacted by telephone, generating a response rate of 36.5 per cent.

Findings: The tested stakeholder framework appears valid and reliable across countries to assess the internal stakeholders of focal firms, as well as their up- and downstream, market and societal stakeholders. This study provides additional empirical support to categorize firms’ stakeholder considerations in sustainable business practices.

Research limitations/implications: This study validates previous findings in terms of Swedish firms’ considerations of internal and external stakeholders in sustainable business practices in relation to one similar country (Norway) and one different country (Spain). The study also shows how the three countries perceive the focal company and societal stakeholders differently. Practical implications: The tested framework sheds light on focal firms’ stakeholder considerations in sustainable business practices and elucidates the extent to which firms’ account for their internal and external stakeholders in sustainable business practices.

Originality/value: This study contributes to the development of valid and reliable stakeholder theory across contexts and through time. In particular, it contributes to the development of a valid and reliable framework to categorize firms’ stakeholder considerations in sustainable business practices. © 2018, Emerald Publishing Limited.

Place, publisher, year, edition, pages
Bingley: Emerald Group Publishing Limited, 2018
Keywords
Stakeholders, Corporate social responsibility, Supply chain management
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-36493 (URN)10.1108/CG-07-2017-0131 (DOI)000433897200003 ()2-s2.0-85043459490 (Scopus ID)
Available from: 2018-03-22 Created: 2018-03-22 Last updated: 2019-05-24Bibliographically approved
Laurell, H. (2018). An international new venture’s commercialization of a medical technology innovation: The role of institutional healthcare settings. International Marketing Review, 35(1), 136-163
Open this publication in new window or tab >>An international new venture’s commercialization of a medical technology innovation: The role of institutional healthcare settings
2018 (English)In: International Marketing Review, ISSN 0265-1335, E-ISSN 1758-6763, Vol. 35, no 1, p. 136-163Article in journal (Refereed) Published
Abstract [en]

Purpose: The purpose of this paper is to explore how different country-specific institutional healthcare settings affect an international new venture’s (INV’s) selling strategies and internationalization process when commercializing a medical technology innovation.

Design/methodology/approach: The study is based on a longitudinal in-depth case study approach with a comparative healthcare analysis in Sweden, UK, Germany and the USA.

Findings: An institutional framework helps elucidate the regulative, normative and cultural-cognitive dimensions in different healthcare settings. National markets differ when operating in a healthcare setting and thus affect both sales patterns and the internationalization process. In this study, three different sales patterns emerged from the countries’ and even regions’ distinctive institutional differences. Although the actual internationalization process starts from the INV’s inception, the subsequent internationalization process was both slow and focused due to institutional diversity and complexity.

Practical implications: Every nation has its own unique healthcare structure, indicating the importance of choosing markets that facilitate a swift uptake of a specific medical technology innovation. Commercializing a medical technology innovation in different country-specific healthcare settings is a lengthy, complex and costly process, especially if new behaviors and routines need to be created.

Originality/value: The paper contributes to the international entrepreneurship-marketing interface by developing an analytical framework for understanding country differences in relation to regulative, normative and culture-cognitive dimensions and by advancing six propositions related to the role of institutional healthcare settings and their impact on INVs’ sales patterns and internationalization processes. © 2018, Emerald Publishing Limited.

Place, publisher, year, edition, pages
Bingley: Emerald Group Publishing Limited, 2018
Keywords
Innovation, Internationalization
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-36492 (URN)10.1108/IMR-04-2015-0112 (DOI)000426881700007 ()2-s2.0-85043354532 (Scopus ID)
Funder
Swedish Research CouncilKnowledge Foundation
Available from: 2018-03-22 Created: 2018-03-22 Last updated: 2018-04-09Bibliographically approved
Laurell, H. & Gabrielsson, J. (2018). Internationalization speed and performance outcomes of international new ventures in the medical technology sector. In: : . Paper presented at The 22nd McGill International Entrepreneurship Conference, 22-24 September, 2018, Halmstad, Sweden.
Open this publication in new window or tab >>Internationalization speed and performance outcomes of international new ventures in the medical technology sector
2018 (English)Conference paper, Oral presentation with published abstract (Refereed)
Abstract [en]

The demand for medical technology innovations for improving and managing human health is global. Many players in markets for medical technology are new ventures operating in relatively small niches (Altenstetter, 2003) and struggling to build capabilities and develop internationalization strategies to scale up production and sales. However, the regulation and financing of the healthcare sector are to a large extent country specific. For example, the healthcare sector in the UK is financed through taxes, while US healthcare is primarily financed through insurance systems (Donaldson et al., 2004). Such differences affect the processes of valuing, buying and paying for medical technology innovations across the different healthcare systems and complicate procurement and reimbursement procedures for new ventures engaged in the commercialization of medical technology innovations. 

The development and commercialization of medical technology innovations are embedded in institutionally complex markets, in which layers of regulative, normative and cultural-cognitive elements (e.g. Scott, 2014) vary significantly across countries. Research that investigates the institutional environment is a promising direction to build theoretical explanations of the impact of heterogeneous markets on international entrepreneurial activities (Etemad, 2013; Jones et al., 2011a, 2011b). However, the international entrepreneurship literature has largely failed to address how institutional cross-country heterogeneity affects the sales and marketing strategies of new ventures (cf. Coeurderoy and Murray, 2008). In addition, only recently has the literature begun developing frameworks that shed better light on the impact of different customer and product types when penetrating new markets (Hennart, 2014; Onetti et al., 2012). 

The global demand for medical technology innovationscalls for better understanding of how differences across national healthcare organizations influence the international performance of medical technology ventures.Against this, in this paper we aim to develop a theoretical framework that explains the relationship between internationalization speed and performance outcomes of international new ventures (INVs) when commercializing medical technology innovations across institutionally heterogeneous markets. Our theory and logic emphasizes factors such as industry conditions, foreign market knowledge and network intensity (Oviatt and McDougall, 2005).In this vein, we acknowledge that it is critical to understand how different actors in the healthcare value chain influence INVs’ choice of countries to enter and whether their existing knowledge bases and networks are aligned with industry- and/or country-specific requirements (e.g. regulations, health economics, clinical trials). However, we also complement and extend general models of international entrepreneurship by identifying institutional healthcare dimensions (i.e. regulative, normative and cultural-cognitive) as moderating forces that explain either the acceleration or deceleration of international sales of medical technology innovations, depending on each country’s institutional healthcare setting. Thus, we suggest that a country’s healthcare setting also affects the sales process of INVs and how quickly they can get medical technology innovations adopted in the healthcare system. Building on our theory and logic, we formulate propositions and illustrate relationships among different constructs. 

This paper contributes to theory and research on international entrepreneurship field. Its main contribution is to better understand the relationship between internationalization speed and performance outcomes for INVs when operating in institutionally heterogeneous healthcaremarkets. Informed by this reasoning, we therefore introduce a conceptual model that specifies different factors that influence internationalization speed and subsequent performance outcomes.

National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-38182 (URN)
Conference
The 22nd McGill International Entrepreneurship Conference, 22-24 September, 2018, Halmstad, Sweden
Available from: 2018-10-18 Created: 2018-10-18 Last updated: 2018-10-19Bibliographically approved
Laurell, H. & Gabrielsson, J. (2017). Adapting the theory of international new ventures to institutionally heterogeneous healthcare markets: Implications for international sales of medical technology innovations. In: Australian Centre for Entrepreneurship (ACE) Research Exchange Conference 2017: . Paper presented at Australian Centre for Entrepreneurship Exchange (ACERE) Conference 2017, Melbourne, Australia, February 7-10, 2017 (pp. 24-25).
Open this publication in new window or tab >>Adapting the theory of international new ventures to institutionally heterogeneous healthcare markets: Implications for international sales of medical technology innovations
2017 (English)In: Australian Centre for Entrepreneurship (ACE) Research Exchange Conference 2017, 2017, p. 24-25Conference paper, Oral presentation with published abstract (Refereed)
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-33763 (URN)
Conference
Australian Centre for Entrepreneurship Exchange (ACERE) Conference 2017, Melbourne, Australia, February 7-10, 2017
Available from: 2017-04-26 Created: 2017-04-26 Last updated: 2017-05-15Bibliographically approved
Laurell, H. & Holmén, M. (2017). Internationalization through business model innovation in the medical technology sector. In: Lucia Piscitello & Stefano Elia (Ed.), Proceedings of the 43rd Annual Conference of the European International Business Academy: International Businessin the Information Age. Paper presented at 43rd Annual Conference of the European International Business Academy (EIBA2017), Milan, Italy, 14th - 16th December 2017 (pp. 59-59).
Open this publication in new window or tab >>Internationalization through business model innovation in the medical technology sector
2017 (English)In: Proceedings of the 43rd Annual Conference of the European International Business Academy: International Businessin the Information Age / [ed] Lucia Piscitello & Stefano Elia, 2017, p. 59-59Conference paper, Poster (with or without abstract) (Refereed)
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-36497 (URN)978-88-6493-042-8 (ISBN)
Conference
43rd Annual Conference of the European International Business Academy (EIBA2017), Milan, Italy, 14th - 16th December 2017
Available from: 2018-03-22 Created: 2018-03-22 Last updated: 2018-06-08Bibliographically approved
Laurell, H., Bollue, S. & Wackerbarth, J. (2017). Internationalization through business model innovation in the medical technology sector – a case study of an international new venture entering the complex German market. In: Australian Centre for Entrepreneurship (ACE) Research Exchange Conference 2017: . Paper presented at Australian Centre for Entrepreneurship Exchange (ACERE) Conference 2017, Melbourne, Australia, February 7-10, 2017 (pp. 25-25).
Open this publication in new window or tab >>Internationalization through business model innovation in the medical technology sector – a case study of an international new venture entering the complex German market
2017 (English)In: Australian Centre for Entrepreneurship (ACE) Research Exchange Conference 2017, 2017, p. 25-25Conference paper, Oral presentation with published abstract (Refereed)
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-33762 (URN)
Conference
Australian Centre for Entrepreneurship Exchange (ACERE) Conference 2017, Melbourne, Australia, February 7-10, 2017
Available from: 2017-04-26 Created: 2017-04-26 Last updated: 2017-05-15Bibliographically approved
Norell Pejner, M., Lundström, J., Ourique de Morais, W., Laurell, H., Isaksson, A., Stranne, F. & Skärsäter, I. (2017). Smart medication organizer – one way to promote self-management and safety in drug administration in elderly people. In: : . Paper presented at Medicinteknikdagarna 2017, Västerås, Sweden, 10-11 October, 2017.
Open this publication in new window or tab >>Smart medication organizer – one way to promote self-management and safety in drug administration in elderly people
Show others...
2017 (English)Conference paper, Oral presentation only (Refereed)
National Category
Medical Engineering Other Medical Engineering
Identifiers
urn:nbn:se:hh:diva-35738 (URN)
Conference
Medicinteknikdagarna 2017, Västerås, Sweden, 10-11 October, 2017
Available from: 2017-12-05 Created: 2017-12-05 Last updated: 2017-12-11Bibliographically approved
Laurell, H., Achtenhagen, L. & Andersson, S. (2017). The changing role of network ties and critical capabilities in an international new venture’s early development. The International Entrepreneurship and Management Journal, 13(1), 113-140
Open this publication in new window or tab >>The changing role of network ties and critical capabilities in an international new venture’s early development
2017 (English)In: The International Entrepreneurship and Management Journal, ISSN 1554-7191, E-ISSN 1555-1938, Vol. 13, no 1, p. 113-140Article in journal (Refereed) Published
Abstract [en]

The importance of networks for firm internationalization has been pointed out for several decades. Especially for small and new firms, networks have been found to be an important tool to gain access to resources and to overcome liabilities of newness, smallness and foreignness. Yet, there is a lack of understanding regarding which types of capabilities are developed through networking and how and when networks are used. The aim of this article is to explore how and when different networking activities develop critical capabilities during different phases of an international new venture’s early development. The article is based on a longitudinal, in-depth case study of a Swedish international new venture from the medical-technology industry. We find that the development process is greatly affected by how the individual key actors leverage their network ties to develop critical capabilities – they use existing network ties and different indirect ties during the pre-founding, start-up and establishment of production phases. During the commercialization and sales growth phases, however, many new network ties are developed. The heterogeneity of the individual actors’ backgrounds plays an important role during the different developmental phases. We conclude by advancing a number of propositions in relation to how critical capabilities are developed through networking during different developmental phases. © 2016, Springer Science+Business Media New York.

Place, publisher, year, edition, pages
New York, NY: Springer-Verlag New York, 2017
Keywords
Internationalization, Networks, Medical-technology sector, International new venture, Longitudinal study, Capabilities
National Category
Business Administration
Identifiers
urn:nbn:se:hh:diva-33381 (URN)10.1007/s11365-016-0398-3 (DOI)000394301700005 ()2-s2.0-84968627105 (Scopus ID)
Funder
Swedish Research Council
Available from: 2017-03-01 Created: 2017-03-01 Last updated: 2018-03-23Bibliographically approved
Organisations

Search in DiVA

Show all publications